Posted on 04/13/2020 3:19:55 PM PDT by SeekAndFind
The University of Kansas Medical Center will be participating in a nationwide clinical trial to evaluate the effectiveness of hydroxychloroquine in preventing COVID-19 infection in exposed health care workers.
KU Medical Center is one of 60 such sites across the nation that will be participating in this clinical trial, led by the Duke Clinical Research Institute.
The trial, the Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO HCQ), will launch April 22.
It is a phase-3 double-blinded clinical trial, funded by the Patient-Centered Outcomes Research Institute. It is accompanied by a registry, launching today, that will create a community of health care workers who have expressed interest in contributing to the scientific community’s understanding of the impact of COVID-19.
Mario Castro, M.D., MPH, vice chair for clinical and translational research and pulmonologist at the University of Kansas School of Medicine, will serve as principal investigator for the KU Medical Center site of the study.
“At this point in the pandemic, hospitals are reporting that 20% of U.S. healthcare workers are becoming infected with COVID-19. When that happens, one in five must go into quarantine and cannot take care of patients,” Castro said. “This study is critical for safeguarding the personal health of these workers and for protecting the health care workforce at this critical time. Our hope is that this drug will decrease the risk of exposed workers developing an active COVID-19 infection.”
KU Medical Center aims to recruit 500 participants to the study while also promoting the registry, which will enroll healthcare workers from throughout the United States, at heroesresearch.org.
The HERO Registry is open to all healthcare workers in the United States, including nurses, therapists, physicians, emergency responders, food service workers and environmental service workers — anyone who works in a setting where people receive healthcare and are exposed to COVID-19.
The plan is to use the registry to locate healthcare workers for the current drug trial, but the registry also will allow healthcare workers to indicate their willingness to participate in future clinical trials regarding COVID-19.
“Healthcare workers on the front lines are critical to the pandemic response,” said Adrian Hernandez, M.D., a Duke professor of cardiology and the administrative principal investigator of the nationwide trial. “To address their needs, we need to do rapid-cycle research and clinical trials,” said Hernandez, who originated the program and is a member of the Duke Clinical Research Institute.
Healthcare workers interested in participating in the hydroxychloroquine clinical trial at KU Medical Center may contact Shelby Almo at salmo@kumc.edu or 913-574-3006, and they also must register at heroesresearch.org. Health care workers interested in learning more or in participating in the registry should visit the website at heroesresearch.org.
I predict that many universities will study HCQ without zinc and when it doesn’t work well, will flood the media with “Trump was wrong.” The addition/subtraction of zinc will be a nuance they will try to hide in their findings.
Yay! I’m trying to get up the courage to call our doctor’s office. He’s also the chief medical poobaa in our county.
A former Republican Governor of Kansas, Dr. Jeff Colyer, has already been doing this along with other colleagues at KU Med helping to treat their patients to overcome this pandemic. I wonder what the current Kansas Governor is doing? Perhaps she will rescue all of the small business owners who have been bankrupted by her executive orders. Or, perhaps not.
how many months will the recruitment take before anyone is actually give the drug? and how many months after that before trial results are published?
i notice that almost all trials being discussed are for prophylaxis and not for cure ... why is that?
i tell you why ... the Democrats and the media and the medical authorities do NOT want a cure! they all want President Trump to be destroyed ...
here’s the study:
https://clinicaltrials.gov/ct2/show/NCT04334148
no results until July 2020, which will be moot by then ...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.